Judge Won't Subject All Fosamax MDL Claims To Lone Pine
The New York federal judge overseeing multidistrict litigation that includes more than 950 suits alleging Merck &. Co. Inc.'s osteoporosis drug Fosamax causes jaw deterioration granted a so-called Lone Pine order...To view the full article, register now.
Already a subscriber? Click here to view full article